Log in to access your PharmaMiles
and download the data
| Last Updated on PharmaCompass | Virtual Booth | Country | Labeler | NDC Package Code | Non Proprietary Name | Start Marketing Date | End Marketing Date | Category Code | Dosage Form (Strength) |
|---|---|---|---|---|---|---|---|---|---|
| 28/06/2025 | Evonik |
Germany |
Evonik Corporation | 72309-004 | Olanzapine Pamoate | 2025-01-22 | 2026-12-31 | DRUG FOR FURTHER PROCESSING | POWDER, FOR SUSPENSION (1mg/mg) |
| 28/06/2025 | Eli Lilly |
U.S.A |
Eli Lilly and Company | 0002-1606 | Olanzapine pamoate | 2009-12-11 | 2025-12-31 | DRUG FOR FURTHER PROCESSING | INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (210mg/1.4mL) |
